UK begins major trial for new inhaler-based COVID-19 treatment

Synairgen's SG018 trial is a randomised placebo-controlled study being conducted in approximately 20 countries enrolling a total of 610 COVID-19 patients who require supplemental oxygen.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3oFHe1d
via IFTTT